JP2004518721A5 - - Google Patents

Download PDF

Info

Publication number
JP2004518721A5
JP2004518721A5 JP2002564496A JP2002564496A JP2004518721A5 JP 2004518721 A5 JP2004518721 A5 JP 2004518721A5 JP 2002564496 A JP2002564496 A JP 2002564496A JP 2002564496 A JP2002564496 A JP 2002564496A JP 2004518721 A5 JP2004518721 A5 JP 2004518721A5
Authority
JP
Japan
Prior art keywords
present
active substance
compound according
activity
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002564496A
Other languages
English (en)
Japanese (ja)
Other versions
JP4408626B2 (ja
JP2004518721A (ja
Filing date
Publication date
Priority claimed from DE10106970A external-priority patent/DE10106970A1/de
Application filed filed Critical
Publication of JP2004518721A publication Critical patent/JP2004518721A/ja
Publication of JP2004518721A5 publication Critical patent/JP2004518721A5/ja
Application granted granted Critical
Publication of JP4408626B2 publication Critical patent/JP4408626B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002564496A 2001-02-15 2002-02-14 新規ベンゾイルグアニジン塩 Expired - Fee Related JP4408626B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10106970A DE10106970A1 (de) 2001-02-15 2001-02-15 Neues Benzoylguanidinsalz
PCT/EP2002/001535 WO2002064563A1 (de) 2001-02-15 2002-02-14 Neues benzoylguanidinsalz

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009166773A Division JP5745215B2 (ja) 2001-02-15 2009-07-15 新規ベンゾイルグアニジン塩

Publications (3)

Publication Number Publication Date
JP2004518721A JP2004518721A (ja) 2004-06-24
JP2004518721A5 true JP2004518721A5 (enExample) 2009-04-16
JP4408626B2 JP4408626B2 (ja) 2010-02-03

Family

ID=7674094

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2002564496A Expired - Fee Related JP4408626B2 (ja) 2001-02-15 2002-02-14 新規ベンゾイルグアニジン塩
JP2009166773A Expired - Fee Related JP5745215B2 (ja) 2001-02-15 2009-07-15 新規ベンゾイルグアニジン塩
JP2013047091A Withdrawn JP2013107906A (ja) 2001-02-15 2013-03-08 新規ベンゾイルグアニジン塩

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2009166773A Expired - Fee Related JP5745215B2 (ja) 2001-02-15 2009-07-15 新規ベンゾイルグアニジン塩
JP2013047091A Withdrawn JP2013107906A (ja) 2001-02-15 2013-03-08 新規ベンゾイルグアニジン塩

Country Status (31)

Country Link
US (2) US20080025919A1 (enExample)
EP (1) EP1362030B1 (enExample)
JP (3) JP4408626B2 (enExample)
KR (1) KR100862176B1 (enExample)
CN (1) CN1222510C (enExample)
AT (1) ATE553078T1 (enExample)
AU (1) AU2002250939B2 (enExample)
BG (1) BG66330B1 (enExample)
BR (1) BR0207867A (enExample)
CA (1) CA2434829C (enExample)
CY (1) CY1112878T1 (enExample)
CZ (1) CZ303277B6 (enExample)
DE (1) DE10106970A1 (enExample)
DK (1) DK1362030T3 (enExample)
EA (1) EA006245B1 (enExample)
EC (1) ECSP034708A (enExample)
EE (1) EE200300393A (enExample)
ES (1) ES2385472T3 (enExample)
HR (1) HRP20030653B1 (enExample)
HU (1) HU230035B1 (enExample)
IL (1) IL156934A (enExample)
NO (1) NO20033299D0 (enExample)
NZ (1) NZ528081A (enExample)
PL (1) PL213300B1 (enExample)
PT (1) PT1362030E (enExample)
RS (1) RS52014B (enExample)
SI (1) SI1362030T1 (enExample)
SK (1) SK287830B6 (enExample)
UA (1) UA74625C2 (enExample)
WO (1) WO2002064563A1 (enExample)
ZA (1) ZA200305365B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10106970A1 (de) * 2001-02-15 2002-08-29 Boehringer Ingelheim Pharma Neues Benzoylguanidinsalz
US6982256B2 (en) 2001-09-07 2006-01-03 Boehringer Ingelheim Pharma Kg Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
DE10144030A1 (de) * 2001-09-07 2003-03-27 Boehringer Ingelheim Pharma Verbesserung der lokalen Verträglichkeit bei intravenöser Verabreichung von 4-(4-(2-Pyrrolylcarbonyl-1-piperazinyl)-3-trifluormethyl-benzoylguanidin
US20110118262A1 (en) * 2008-07-08 2011-05-19 Boehringer Ingelheim International Gmbh Pyrrolidinyl and Piperidinyl Compounds Useful as NHE-1 Inhibitiors
US10405746B2 (en) * 2014-04-14 2019-09-10 The University Of Memphis Research Foundation Wireless analog passive sensors
US12369831B1 (en) 2018-04-30 2025-07-29 Bashir I. Morshed Apparatus and method to capture body signals with conjugate coils and paired coils

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19601303A1 (de) * 1996-01-16 1997-07-17 Boehringer Ingelheim Kg Neuartige Benzoylguanidin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln
DE19843489B4 (de) * 1998-09-22 2006-12-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung
US6323207B1 (en) * 1998-09-22 2001-11-27 Boehringer Ingelheim Pharma Kg Benzoylguanidine derivatives
US6730678B2 (en) * 2001-02-15 2004-05-04 Boehringer Ingelheim Pharma Kg Benzoylguanidine salt and hydrates thereof
DE10106970A1 (de) * 2001-02-15 2002-08-29 Boehringer Ingelheim Pharma Neues Benzoylguanidinsalz

Similar Documents

Publication Publication Date Title
RU2001121186A (ru) Производные пиразолкарбоновой кислоты, их получение, содержащие их фармацевтические композиции
JP2004501930A5 (enExample)
WO1999052525A1 (es) Tienilazolilalcoxietanaminas, su preparacion y su aplicacion como medicamentos
SK13302002A3 (sk) V podstate nehydratovaná a nehygroskopická alebo iba mierne hygroskopická hydrochloridová soľ 5-[4-[2-(N-metyl-N-(2- pyridyl)amino) etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
CN1238342C (zh) 新型氨氯地平樟脑磺酸盐及其制备方法
EP0579681B1 (en) Crystalline tiagabine hydrochloride monohydrate, its preparation and use
JP7241807B2 (ja) 15β-ヒドロキシ-酢酸オサテロンの結晶多形
US7205413B2 (en) Solvates and polymorphs of ritonavir and methods of making and using the same
KR20020028873A (ko) 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
JP2004518721A5 (enExample)
KR20170061493A (ko) 피마살탄의 신규 염
JP2008503575A5 (enExample)
ES2277960T3 (es) Base libre de la amlodipina.
WO2004064771A3 (en) Geminally di-substituted nsaid derivatives as abeta 42 lowering agents
CN1295229C (zh) 紫杉烷衍生物的结晶及其制备方法
JP2006500334A (ja) アムロジピンの有機酸塩
WO2004026834A1 (en) Crystalline organic acid salt of amlodipine
JP2008526835A (ja) シブトラミンのスルホン酸塩
JP2005538103A (ja) アムロジピンの有機酸塩
JP2000309588A (ja) 固体分散体
CN101528696A (zh) 晶态s-(-)-氨氯地平无水己二酸盐及其制备方法
KR100462304B1 (ko) 암로디핀의 유기산염
US6890944B2 (en) Organic acid salt of amlodipine
US20060025444A1 (en) Fexofenadine base polymorphic forms
JP2007516164A5 (enExample)